Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 10, Issue 8, pp. 1226-1239
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 23, 2019
- Revision received April 22, 2020
- Accepted June 2, 2020
- Published first June 8, 2020.
Article Versions
- Previous version (June 8, 2020 - 05:50).
- Previous version (July 14, 2020 - 06:10).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Hui Liu1,*,
- Marcia N. Paddock2,
- Haibin Wang3,
- Charles J. Murphy2,4,
- Renee C. Geck1,
- Adrija J. Navarro1,
- Gerburg M. Wulf5,
- Olivier Elemento4,
- Volker Haucke3,
- Lewis C. Cantley2,* and
- Alex Toker1,6,*
- 1Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
- 2Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
- 3Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
- 4Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York.
- 5Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
- 6Ludwig Center at Harvard, Boston, Massachusetts.
- ↵*Corresponding Authors:
Alex Toker, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, EC/CLS-633A, Boston, MA 02215. Phone: 617-735-2482; Fax: 617-735-2480; E-mail: atoker{at}bidmc.harvard.edu; Lewis C. Cantley, The Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, 413 East 69th Street, 13th Floor, Box 50, New York, NY 10021. Phone: 646-962-6132; Fax: 646-962-0575; E-mail: LCantley{at}med.cornell.edu; and Hui Liu, Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, CLS-628, Boston, MA 02215. Phone: 617-275-3922; E-mail: hliu5{at}bidmc.harvard.edu
August 2020
Volume 10, Issue 8
Volume 10, Issue 8
The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer
Jump to section
Advertisement